Area of Interest:

Pharmacology and Toxicology

100%

Pharmaceutical Research

62%

Medicinal Chemistry

90%

Pharmacokinetics

75%

Drug Delivery

55%

Research Publications in Numbers

Books
0

Chapters
0

Articles
0

Abstracts
0

Selected Publications

Shi, Y., M. Zhou, J. Zhang and W. Lu, 2015. Preparation and cellular targeting study of VEGF-conjugated PLGA nanoparticles. J. Microencapsulation, 32: 699-704.
CrossRef | Direct Link |
Lu, W., P. Li, Y. Shan, P. Su, J. Wang, Y. Shi and J. Zhang, 2015. Discovery of biphenyl-based VEGFR-2 inhibitors. Part 3: Design, synthesis and 3D-QSAR studies. Bioorg. Med. Chem., 23: 1044-1054.
CrossRef | Direct Link |
Lu, W., F. Wang, T. Zhang, J. Dong and H. Gao et al., 2014. Search for novel histone deacetylase inhibitors. Part II: Design and synthesis of novel isoferulic acid derivatives. Bioorg. Med. Chem., 22: 2707-2713.
CrossRef | Direct Link |
Zheng, N., M. Zhou, C. Du, S. Wang and W. Lu, 2013. 5-Fluorouracil delivery from a novel three-dimensional micro-device: In vitro and in vivo evaluation. Arch. Pharmacal Res., 36: 1487-1493.
CrossRef | Direct Link |
Zheng, N., M. Zhou and W. Lu, 2013. In vivo distribution of 5-fluorouracil after peritumoral implantation using a biodegradable micro-device in tumor-bearing mice. Eur. J. Drug Metab. Pharmacokinet., 38: 183-190.
CrossRef | PubMed | Direct Link |
Ren, X., N. Zheng, Y. Gao, T. Chen and W. Lu, 2012. Biodegradable three-dimension micro-device delivering 5-fluorouracil in tumor bearing mice. Drug Deliv., 19: 36-44.
CrossRef | Direct Link |
Pan, X., W. Lu, P. Li, F. Wang, C. Wang, Z. Hu and J. Zhang, 2012. A novel and facile synthetic approach for tasigna. Med. Chem., 8: 985-989.
CrossRef | PubMed | Direct Link |
Lu, W., F. Yang and S. Wang, 2012. Development of an HPLC fingerprint for quality control and species differentiation of Uncaria rhynchophylla (Miq.) ex Havil. Acta Chromatogr., 24: 643-651.
CrossRef | Direct Link |
Lu, W., B. Dai, W. Ma and Y. Zhang, 2012. A novel taspine analog, HMQ1611, inhibits growth of non-small cell lung cancer by inhibiting angiogenesis. Oncol. Lett., 4: 1109-1113.
CrossRef | Direct Link |
Pan, J., W. Lu, C. Li, S. Wang and L. He, 2010. Imperatorin sustained-release tablets: In vitro and pharmacokinetic studies. Arch. Pharmacal Res., 33: 1209-1216.
CrossRef | PubMed | Direct Link |